Mural Oncology
MURA
MURA was delisted on the 4th of December, 2025.
76 hedge funds and large institutions have $30.2M invested in Mural Oncology in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 9 closing their positions.
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
3% more funds holding
Funds holding: 74 → 76 (+2)
1% more capital invested
Capital invested by funds: $29.8M → $30.2M (+$389K)
0.92% less ownership
Funds ownership: 55.88% → 54.96% (-0.92%)
26% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 23
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $111K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$311K |
| 2 |
Goldman Sachs
New York
|
+$231K |
| 3 |
Morgan Stanley
New York
|
+$180K |
| 4 |
VF
Virtu Financial
New York
|
+$141K |
| 5 |
Renaissance Technologies
New York
|
+$125K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFA
Alta Fundamental Advisers
New York
|
-$2.25M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.05M |
| 3 |
CC
Centiva Capital
New York
|
-$638K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$469K |
| 5 |
AGM
Alpine Global Management
New York
|
-$457K |
MURA Hedge Fund Activity: Q4 2024 in Review
76 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q4 2024, worth a combined $30.2M — up 1.3% from $29.8M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new MURA positions and 9 closed out — a net gain of 2 holders — while 17 added to existing stakes and 23 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $311K. The largest seller was Alta Fundamental Advisers, exiting entirely with an estimated $2.25M sold.
- 76 institutional investors held Mural Oncology (MURA) as of Q4 2024, up from 74 in Q3 2024.
- Funds reported $30.2M of Mural Oncology stock for Q4 2024, up 1.3% quarter-over-quarter.
- 11 funds opened new Mural Oncology positions in Q4 2024 and 9 closed out, a net change of +2 holders.
- The largest Mural Oncology buyer in Q4 2024 was Citadel Advisors, an estimated $311K added.
- The largest Mural Oncology seller in Q4 2024 was Alta Fundamental Advisers, an estimated $2.25M sold.
Based on aggregated 13F filings for Q4 2024.